Why is Panacea Biotec falling/rising?

As of 28-Aug, Panacea Biotec Ltd is experiencing a decline in its stock price, currently at Rs 388.00, reflecting a decrease of Rs 5.0 or 1.27%. The stock has underperformed its sector by 0.43% today and has been on a downward trend for the last three days, with a total decline of 4.53% during this period. The stock reached an intraday high of Rs 403.25 but also fell to a low of Rs 385. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite a strong performance over the past year with a return of 56.67%, the company is facing significant challenges, including operating losses and a weak long-term fundamental strength, as indicated by a negative EBIT to Interest ratio and poor growth in operating profit.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has declined by 4.72% over the past month while the Sensex has only fallen by 1.00%. This underperformance is compounded by the fact that domestic mutual funds hold no stake in the company, which may indicate a lack of confidence in its valuation or business prospects. Additionally, the stock's liquidity appears adequate for trading, but the overall sentiment is cautious due to the company's negative EBITDA and declining cash reserves, which could further impact investor confidence and contribute to the stock's downward trajectory.